Page last updated: 2024-10-28

beta-thujaplicin and Pneumonia, Pneumococcal

beta-thujaplicin has been researched along with Pneumonia, Pneumococcal in 1 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.

Research Excerpts

ExcerptRelevanceReference
"Antibiotics are the primary line of treatment for pneumococcal pneumonia; however, rising antimicrobial resistance is becoming more prevalent."1.56Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model. ( Domon, H; Hiyoshi, T; Isono, T; Kunitomo, E; Maekawa, T; Nagai, K; Noiri, Y; Takenaka, S; Tamura, H; Terao, Y; Yanagihara, K, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Isono, T1
Domon, H1
Nagai, K1
Maekawa, T1
Tamura, H1
Hiyoshi, T1
Yanagihara, K1
Kunitomo, E1
Takenaka, S1
Noiri, Y1
Terao, Y1

Other Studies

1 other study available for beta-thujaplicin and Pneumonia, Pneumococcal

ArticleYear
Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Animals; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Cytokines; Drug Resis

2020